Clinical Trial Update: OTO-313 in Subjects With Unilateral Subjective Tinnitus [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update for OTO-313 in unilateral subjective tinnitus has completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Subjective Tinnitus

Drugs mentioned

• OTO-313

Snippet

Sponsor: Otonomy, Inc. | Conditions: Subjective Tinnitus | Phase 2 | Status: COMPLETED | Results posted: 2023-01-06